3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
16
Uterine Cervical Neoplasms
8
Melanoma
7
Colorectal Neoplasms
7
Fallopian Tube Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Breast Neoplasms
5
Recurrence
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Turcot syndrome
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
pembrolizumab
5
Cyclophosphamide
4
Carboplatin
4
Filgrastim
3
fludarabine
2
Thiotepa
2
Temozolomide
2
Riluzole
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Immunohistochemistry
2
Drug Therapy
2
Counseling
2
Bupropion
2
vofatamab
1
utomilumab
1
trastuzumab deruxtecan
1
toripalimab
1
tasquinimod
1
sodium thiosulfate
1
sargramostim
1
saracatinib
1
poly ICLC
1
pertuzumab
1
liposomal doxorubicin
1
lenvatinib
1
ixabepilone
1
etoposide phosphate
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Gynecologic
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled